![](/img/cover-not-exists.png)
SECOND PRIMARY MALIGNANCIES IN MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB: REAL WORLD EVIDENCE FROM 215 CONSECUTIVELY TREATED PATIENTS IN LOMBARDY
Maffioli, M., Giorgino, T., Mora, B., Iurlo, A., Elli, E., Finazzi, M. C., Caramella, M., Rumi, E., Carraro, M. C., Polverelli, N., DʼAdda, M., Malato, S., Rossi, M., Molteni, A., Vismara, A., Sissa,Volume:
3
Journal:
HemaSphere
DOI:
10.1097/01.hs9.0000564112.29135.44
Date:
June, 2019
File:
PDF, 792 KB
2019